JP2005531281A - 肺癌の治療および診断 - Google Patents

肺癌の治療および診断 Download PDF

Info

Publication number
JP2005531281A
JP2005531281A JP2003542564A JP2003542564A JP2005531281A JP 2005531281 A JP2005531281 A JP 2005531281A JP 2003542564 A JP2003542564 A JP 2003542564A JP 2003542564 A JP2003542564 A JP 2003542564A JP 2005531281 A JP2005531281 A JP 2005531281A
Authority
JP
Japan
Prior art keywords
expression
gene
lung cancer
subject
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003542564A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005531281A5 (https=
Inventor
ジーン エス． ビーブ，
ケビン ジー． コールマン，
イーサン ドミトロブスキー，
トーマス ジー． トゥリ，
Original Assignee
ファイザー・プロダクツ・インク
トラスティーズ・オブ・ダートマウス・カレッジ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファイザー・プロダクツ・インク, トラスティーズ・オブ・ダートマウス・カレッジ filed Critical ファイザー・プロダクツ・インク
Publication of JP2005531281A publication Critical patent/JP2005531281A/ja
Publication of JP2005531281A5 publication Critical patent/JP2005531281A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2003542564A 2001-11-02 2002-11-02 肺癌の治療および診断 Pending JP2005531281A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33629801P 2001-11-02 2001-11-02
US33531701P 2001-11-02 2001-11-02
US33602401P 2001-11-02 2001-11-02
PCT/US2002/035149 WO2003040317A2 (en) 2001-11-02 2002-11-02 Lung cancer therapeutics and diagnostics

Publications (2)

Publication Number Publication Date
JP2005531281A true JP2005531281A (ja) 2005-10-20
JP2005531281A5 JP2005531281A5 (https=) 2006-01-05

Family

ID=27407051

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003542564A Pending JP2005531281A (ja) 2001-11-02 2002-11-02 肺癌の治療および診断

Country Status (5)

Country Link
US (1) US20030219768A1 (https=)
EP (1) EP1520032A4 (https=)
JP (1) JP2005531281A (https=)
AU (1) AU2002353972A1 (https=)
WO (1) WO2003040317A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006107395A (ja) * 2004-10-08 2006-04-20 Ns Solutions Corp 化合物推定装置、化合物推定方法及びそのプログラム
JP2007507814A (ja) * 2003-10-07 2007-03-29 エンテロス・インコーポレーテッド 患者に固有の結果のシミュレーション

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1606305A4 (en) * 2003-03-12 2009-06-24 Vasgene Therapeutics Inc NUCLEIC ACID COMPOUNDS FOR THE INHIBITION OF ANGIOGENESIS AND TUMOR GROWTH
CA2527680A1 (en) * 2003-05-30 2005-06-02 Astrazeneca Uk Limited Markers for responsiveness to an erbb receptor tyrosine kinase inhibitor
US20070270504A1 (en) * 2003-06-20 2007-11-22 Avalon Pharmaceuticals, Inc. Identification of Therapeutic Agents Using Genetic Fingerprinting
WO2005032495A2 (en) * 2003-10-03 2005-04-14 Bayer Pharmaceuticals Corporation Gene expression profiles and methods of use
US20060088862A1 (en) * 2004-09-30 2006-04-27 Nancy Lee Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods, and kits thereof
EP1806581A4 (en) * 2004-10-28 2011-08-17 Seems Inc DISEASE DIAGNOSTIC SYSTEM
EP1829967A4 (en) * 2004-12-03 2008-04-23 Aichi Prefecture METHOD FOR DIAGNOSIS OF MALIGNEM LYMPHOMA AND ASSESSMENT OF THE FORECASTING THEREOF
EP3211093A1 (en) * 2005-04-14 2017-08-30 The Trustees of Boston University Diagnostic for lung disorders using class prediction
WO2007103541A2 (en) 2006-03-09 2007-09-13 The Trustees Of Boston University Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
WO2008039071A2 (en) * 2006-09-29 2008-04-03 Agendia B.V. High-throughput diagnostic testing using arrays
WO2009039190A1 (en) 2007-09-17 2009-03-26 Gene Express, Inc. Cancer risk biomarker
WO2009123990A1 (en) * 2008-03-31 2009-10-08 The University Of Toledo Cancer risk biomarker
US8652798B2 (en) * 2008-05-20 2014-02-18 The Regents Of The University Of California Analysis of ex vivo cells for disease state detection and therapeutic agent selection and monitoring
WO2010011642A2 (en) * 2008-07-21 2010-01-28 The Trustees Of The University Of Pennsylvania Methods and compositions using splicing regulatory proteins involved in tumor suppression
AU2011316986A1 (en) * 2010-10-20 2013-06-06 Rush University Medical Center Lung cancer tests
US9687467B2 (en) 2011-04-04 2017-06-27 Children's Medical Center Corporation Diagnosis and treatment of taxane-resistant cancers
US10338073B2 (en) 2011-04-14 2019-07-02 Raymond U. Osarogiagbon Lymph node specimen collection kit and method of pathological analysis for lung cancer diagnosis using such a kit
US9753037B2 (en) 2013-03-15 2017-09-05 Rush University Medical Center Biomarker panel for detecting lung cancer
EP3080299B1 (en) 2013-12-09 2020-09-30 Rush University Medical Center Biomarkers of rapid progression in advanced non-small cell lung cancer
WO2017197335A1 (en) 2016-05-12 2017-11-16 Trustees Of Boston University Nasal epithelium gene expression signature and classifier for the prediction of lung cancer
CN110574414B (zh) 2016-12-27 2023-04-04 株式会社电装 用于微定位传感器通信的系统和方法
WO2021158713A1 (en) * 2020-02-03 2021-08-12 Tdl Innovations Llc Foam compositions for the treatment of cancer
CN118969273B (zh) * 2024-07-25 2025-02-28 常州贝格尔医学检验实验室有限公司 一种靶向用药方案的评价方法及系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002509707A (ja) * 1998-03-31 2002-04-02 ジェンザイム・コーポレーション 肺腫瘍細胞を同定するための組成物および方法
AU4651500A (en) * 1999-04-23 2000-11-10 Corixa Corporation Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma
EP1242598A2 (en) * 1999-12-30 2002-09-25 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
WO2001060860A2 (en) * 2000-02-17 2001-08-23 Millennium Predictive Medicine, Inc. Genes differentially expressed in human prostate cancer and their use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007507814A (ja) * 2003-10-07 2007-03-29 エンテロス・インコーポレーテッド 患者に固有の結果のシミュレーション
JP2006107395A (ja) * 2004-10-08 2006-04-20 Ns Solutions Corp 化合物推定装置、化合物推定方法及びそのプログラム

Also Published As

Publication number Publication date
WO2003040317A2 (en) 2003-05-15
AU2002353972A1 (en) 2003-05-19
EP1520032A2 (en) 2005-04-06
WO2003040317A8 (en) 2005-02-03
EP1520032A4 (en) 2007-07-18
US20030219768A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
JP2005531281A (ja) 肺癌の治療および診断
EP3213240B1 (en) Methods and systems for identifying ligand-protein binding sites
US10563264B2 (en) Methods for assessing risk of developing a viral disease using a genetic test
US20060195266A1 (en) Methods for predicting cancer outcome and gene signatures for use therein
US20220127676A1 (en) Methods and compositions for prognostic and/or diagnostic subtyping of pancreatic cancer
US20030138793A1 (en) Molecular signatures of commonly fatal carcinomas
EP3198035A2 (en) Methods for predicting drug responsiveness
WO2004066941A2 (en) Expression profiles for colon cancer and methods of use
CN101313306A (zh) 用于鉴别鼻咽癌中的预后型亚类的基因表达谱
US20060240441A1 (en) Gene expression profiles and methods of use
WO2005059108A2 (en) Gene expression profiles and methods of use
US20200270702A1 (en) Classification of diffuse large b-cell lymphoma
JP2010166915A (ja) 薬物処置の副作用としての浮腫を予測する方法
EP2419540B1 (en) Methods and gene expression signature for assessing ras pathway activity
US20150247203A1 (en) Composition for detecting the response of rectal adenocarcinomas to radiochemotherapy
JP2006524502A (ja) 乳癌の発現プロファイル及び使用法
US20050164196A1 (en) Methods to predict patient responsiveness to tyrosine kinase inhibitors
AU2021286282B2 (en) Chromosome conformation markers of prostate cancer and lymphoma
JP2005531280A (ja) 赤血球生成障害用治療薬および診断薬
US20050084872A1 (en) Methods for determining whether an agent possesses a defined biological activity
Lee et al. Using microarrays to predict resistance to chemotherapy in cancer patients
US20040161765A1 (en) Methods and compositions for identifying disease genes using nonsense-mediated decay inhibition
US20050037369A1 (en) Panels of molecular targets differentially expressed during CD8+ T cell priming, and methods for therapy and diagnosis utilizing the same
US20040235019A1 (en) Diagnostics and therapeutics for the gene expression signature of PPAR-gamma receptor ligand
WO2005083128A2 (en) Methods for predicting cancer outcome and gene signatures for use therein

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051101

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051101

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081127

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090421